Collection
Sphingomyelin: Key Roles in Health and Disease
- Submission status
- Closed
Lipids in Health and Disease invites you to contribute a manuscript to our new thematic series, “Sphingomyelin: Key Roles in Health and Disease”.
Sphingolipids were named after the mythological sphinx because of their enigmatic nature. Sphingolipids, like the sphinx, are composed of diverse subunits: an amino diol, sphingosine, bound to a fatty acid by an amide linkage, and a polar head group. Perhaps the best known sphinx is the Great Sphinx of Giza. Similarly famous and enigmatic is sphingomyelin (SM), which contains predominantly a phosphocholine as head group. Sphingomyelin is abundant in the outer leaflet of cell plasma membranes where it with cholesterol forms lipid rafts, which serve as platforms for proteins and protein assemblies involved in signal transduction. Additionally, SM is the most abundant sphingolipid in plasma lipoproteins. Removal of the head group phosphocholine by sphingomyelinases generates a product with hydrogen as head group, ceramide, an apoptosis-inducing, and messenger death molecule.
Accumulation of SM and decrease in ceramide levels are implicated in tumor initiation, immune evasion, growth, and metastasis. Additionally, reports document SM roles in atherosclerosis, Alzheimer, and diseases mediated by human immunodeficiency virus and prion invasion. Interactions of sphingolipid metabolism of numerous parasites, such as Plamodium, Trypanosoma, Toxoplasma, Schistosoma with that of the host contribute to parasite survival and/or host defense.
We wish to welcome articles, including original research, narrative reviews, systematic reviews and meta-analysis, and mini-reviews which establish the relation between SM metabolism and cancer immune evasion, thus allowing the discovery of unprecedented approaches and new molecules for cancer prevention and therapy. Of great interest would be articles clarifying the intricacies of SM involvement in atherosclerosis, diabetes, Alzheimer, and diseases caused by viruses and prion. Such articles are expected to open avenues for prevention and therapy of these severe afflictions. The topics that will be particularly welcomed for submission in the issue are those addressing the identification and characterization of SM-related virulence factors and pathways of human parasites, and aiming towards development of novel therapeutic options and molecules.
Articles (12 in this collection)
-
-
Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients
Authors (first, second and last of 10)
- Aina Vaivade
- Anna Wiberg
- Kim Kultima
- Content type: Research
- Open Access
- Published: 07 July 2023
- Article: 97
-
Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease
Authors (first, second and last of 7)
- Zongqiang Hu
- Hongyu Zhang
- Li Li
- Content type: Research
- Open Access
- Published: 07 March 2023
- Article: 33
-
Determination of endogenous sphingolipid content in stroke rats and HT22 cells subjected to oxygen-glucose deprivation by LC‒MS/MS
Authors (first, second and last of 5)
- Keqi Zeng
- Xin Zhou
- Yingfeng Zhang
- Content type: Research
- Open Access
- Published: 25 January 2023
- Article: 13
-
The relationship between NAFLD and retinol-binding protein 4 - an updated systematic review and meta-analysis
Authors (first, second and last of 4)
- Rui Hu
- Xiaoyue Yang
- Guangyao Song
- Content type: Review
- Open Access
- Published: 21 January 2023
- Article: 8
-
Relationship between early-onset stroke and triglyceride-glucose index among young Chinese adults
Authors (first, second and last of 10)
- Wenqi Xu
- Haiyan Zhao
- Yuntao Wu
- Content type: Research
- Open Access
- Published: 11 January 2023
- Article: 3
-
Effects of camelina oil supplementation on lipid profile and glycemic control: a systematic review and dose‒response meta-analysis of randomized clinical trials
Authors (first, second and last of 10)
- Cyrus Jalili
- Sepide Talebi
- Sajjad Moradi
- Content type: Review
- Open Access
- Published: 07 December 2022
- Article: 132
-
CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease
Authors (first, second and last of 7)
- Xinlu Yuan
- Yanyan Li
- Ligang Zhou
- Content type: Research
- Open Access
- Published: 29 November 2022
- Article: 127
-
Effects of sphingolipid metabolism disorders on endothelial cells
Authors (first, second and last of 5)
- Yali Lai
- Yue Tian
- Jianmei Huang
- Content type: Review
- Open Access
- Published: 13 October 2022
- Article: 101
-
Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate
Authors (first, second and last of 5)
- Moritz Liebmann
- Katharina Grupe
- Stephan Scherneck
- Content type: Research
- Open Access
- Published: 08 October 2022
- Article: 99
-
Potential novel biomarkers in small intestine for obesity/obesity resistance revealed by multi-omics analysis
Authors (first, second and last of 6)
- Yueshan Pang
- Yali Zheng
- WeiJun Ding
- Content type: Research
- Open Access
- Published: 08 October 2022
- Article: 98
-
Fat-to-muscle ratio as a predictor for dyslipidaemia in transitional-age youth
Authors (first, second and last of 11)
- Jia-Xing Zhang
- Wen Li
- Yu-Hong Zhang
- Content type: Research
- Open Access
- Published: 19 September 2022
- Article: 88